| Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy I Chourpa, L Douziech-Eyrolles, L Ngaboni-Okassa, JF Fouquenet, ... Analyst 130 (10), 1395-1403, 2005 | 401 | 2005 |
| Comparative study of doxorubicin-loaded poly (lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods F Tewes, E Munnier, B Antoon, LN Okassa, S Cohen-Jonathan, ... European journal of pharmaceutics and biopharmaceutics 66 (3), 488-492, 2007 | 248 | 2007 |
| Novel method of doxorubicin–SPION reversible association for magnetic drug targeting E Munnier, S Cohen-Jonathan, C Linassier, L Douziech-Eyrolles, ... International journal of pharmaceutics 363 (1-2), 170-176, 2008 | 169 | 2008 |
| The development of stable aqueous suspensions of PEGylated SPIONs for biomedical applications K Herve, L Douziech-Eyrolles, E Munnier, S Cohen-Jonathan, M Souce, ... Nanotechnology 19 (46), 465608, 2008 | 150 | 2008 |
| Optimization of iron oxide nanoparticles encapsulation within poly (d, l-lactide-co-glycolide) sub-micron particles LN Okassa, H Marchais, L Douziech-Eyrolles, K Hervé, ... European Journal of Pharmaceutics and Biopharmaceutics 67 (1), 31-38, 2007 | 144 | 2007 |
| Development and characterization of sub-micron poly (D, L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles LN Okassa, H Marchais, L Douziech-Eyrolles, S Cohen-Jonathan, ... International Journal of Pharmaceutics 302 (1-2), 187-196, 2005 | 115 | 2005 |
| Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo É Allard-Vannier, S Cohen-Jonathan, J Gautier, K Hervé-Aubert, ... European journal of pharmaceutics and biopharmaceutics 81 (3), 498-505, 2012 | 79 | 2012 |
| Synthesis and evaluation of novel biocompatible super-paramagnetic iron oxide nanoparticles as magnetic anticancer drug carrier and fluorescence active label A Shkilnyy, E Munnier, K Hervé, M Soucé, R Benoit, S Cohen-Jonathan, ... The Journal of Physical Chemistry C 114 (13), 5850-5858, 2010 | 60 | 2010 |
| Novel alginate-based nanocarriers as a strategy to include high concentrations of hydrophobic compounds in hydrogels for topical application HTP Nguyen, E Munnier, M Soucé, X Perse, S David, F Bonnier, F Vial, ... Nanotechnology 26 (25), 255101, 2015 | 46 | 2015 |
| Doxorubicin delivered to MCF-7 cancer cells by superparamagnetic iron oxide nanoparticles: effects on subcellular distribution and cytotoxicity E Munnier, S Cohen-Jonathan, K Hervé, C Linassier, M Soucé, P Dubois, ... Journal of Nanoparticle Research 13, 959-971, 2011 | 42 | 2011 |
| On the interaction of doxorubicin with oleate ions: fluorescence spectroscopy and liquid–liquid extraction study E Munnier, F Tewes, S Cohen-Jonathan, C Linassier, ... Chemical and pharmaceutical bulletin 55 (7), 1006-1010, 2007 | 35 | 2007 |
| Mapping chemical and structural composition of pharmaceutical and biological samples by Raman, surface-enhanced Raman and fluorescence spectral imaging I Chourpa, S Cohen-Jonathan, P Dubois Raman Imaging: Techniques and Applications, 243-255, 2012 | 1 | 2012 |
| Stealth properties of pegylated magnetic nanoparticles for drug targeting applications S Cohen-Jonathan, C Passirani-Malleret, I Chourpa, E Allard-Vannier, ... APGI-7th world meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical …, 2010 | | 2010 |
| Raman and SERS microspectroscopic study of anticancer drug doxorubicin ionically bound to superparamagnetic iron oxide nanoparticles I Chourpa, L Douziech-Eyrolles, E Sarazin, LN Okassa, M Soucé, ... Science Access 2 (1), 126-127, 2004 | | 2004 |
| Intérêt de la FRX-RT (Fluorescence des Rayons X à Réflexion Totale) pour le suivi de la pollution des eaux des rivières par les métaux: Cas de oued Bouregreg (Maroc) A El Hamdaoui, S Cohen-Jonathan, M Bounakhla, P Dubois, MI Majah Cahiers de l'Association Scientifique Européenne pour l'Eau et la Santé 7 (1 …, 2002 | | 2002 |
| UNCORRECTED PAPER HTP Nguyen, E Munnier, M Soucé, X Perse, S David, F Bonnier, F Vial, ... | | |
